APA

Douglas M., Lim A. R., Porter J. R., West K., Pink M. M., Ge J., Wylie A. A., Tibbits T. T., Biggs K., Curtis M., Palombella V. J., Adams J., Fritz C. C. & Normant E. (20100324). The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo. : Molecular cancer therapeutics.

Chicago

Douglas Mark, Lim Alice R, Porter James R, West Kip, Pink Melissa M, Ge Jie, Wylie Andrew A, Tibbits Thomas T, Biggs Kurtis, Curtis Michael, Palombella Vito J, Adams Julian, Fritz Christian C and Normant Emmanuel. 20100324. The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo. : Molecular cancer therapeutics.

Harvard

Douglas M., Lim A. R., Porter J. R., West K., Pink M. M., Ge J., Wylie A. A., Tibbits T. T., Biggs K., Curtis M., Palombella V. J., Adams J., Fritz C. C. and Normant E. (20100324). The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo. : Molecular cancer therapeutics.

MLA

Douglas Mark, Lim Alice R, Porter James R, West Kip, Pink Melissa M, Ge Jie, Wylie Andrew A, Tibbits Thomas T, Biggs Kurtis, Curtis Michael, Palombella Vito J, Adams Julian, Fritz Christian C and Normant Emmanuel. The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo. : Molecular cancer therapeutics. 20100324.